Cargando…

Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development

The transcription factor NRF2 (nuclear factor erythroid 2-related factor 2) triggers the first line of homeostatic responses against a plethora of environmental or endogenous deviations in redox metabolism, proteostasis, inflammation, etc. Therefore, pharmacological activation of NRF2 is a promising...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robledinos-Antón, Natalia, Fernández-Ginés, Raquel, Manda, Gina, Cuadrado, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664516/ https://www.ncbi.nlm.nih.gov/pubmed/31396308 http://dx.doi.org/10.1155/2019/9372182

Ejemplares similares

WIP Modulates Oxidative Stress through NRF2/KEAP1 in Glioblastoma Cells
por: Escoll, Maribel, et al.
Publicado: (2020)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
por: Escoll, Maribel, et al.
Publicado: (2020)

Can Activation of NRF2 Be a Strategy against COVID-19?
por: Cuadrado, Antonio, et al.
Publicado: (2020)

NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signaling
por: Martin-Hurtado, Ana, et al.
Publicado: (2019)

Transcription factor NRF2 controls the fate of neural stem cells in the subgranular zone of the hippocampus
por: Robledinos-Antón, Natalia, et al.
Publicado: (2017)

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
por: Bourdakou, Marilena M., et al.
Publicado: (2023)

TAZ Represses the Neuronal Commitment of Neural Stem Cells
por: Robledinos-Antón, Natalia, et al.
Publicado: (2020)

An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver
por: Fernández-Ginés, Raquel, et al.
Publicado: (2022)

Corrigendum to “An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver” [Redox Biol. 55 (2022) 102396/PMID: 35839629]
por: Fernández-Ginés, Raquel, et al.
Publicado: (2022)

Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases
por: Manda, Gina, et al.
Publicado: (2020)

KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential
por: Crisman, Enrique, et al.
Publicado: (2022)

Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
por: Zhang, Juan, et al.
Publicado: (2023)

Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
por: Duarte, Pablo, et al.
Publicado: (2022)

Potential Applications of NRF2 Inhibitors in Cancer Therapy
por: Panieri, Emiliano, et al.
Publicado: (2019)

Pharmacology and Clinical Drug Candidates in Redox Medicine
por: Dao, V. Thao-Vi, et al.
Publicado: (2015)

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
por: Pajares, Marta, et al.
Publicado: (2020)

NRF2 and Primary Cilia: An Emerging Partnership
por: Martin-Hurtado, Ana, et al.
Publicado: (2020)

Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2019)

Transcription Factor Nrf2: a novel target to modulate inflammatory and neuroprotective responses in Parkinson’s disease
por: Cuadrado, Antonio
Publicado: (2015)

Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases
por: Pajares, Marta, et al.
Publicado: (2017)

Decreased neural precursor cell pool in NADPH oxidase 2-deficiency: From mouse brain to neural differentiation of patient derived iPSC
por: Nayernia, Zeynab, et al.
Publicado: (2017)

Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
por: Sharifi-Rad, Javad, et al.
Publicado: (2023)

Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer’s Disease, Common to APP(V717I) × TAU(P301L) Mice and Patients
por: Cucos, Catalina Anca, et al.
Publicado: (2022)

An update of Nrf2 activators and inhibitors in cancer prevention/promotion
por: Pouremamali, Farhad, et al.
Publicado: (2022)

Disabling the Protease DDI2 Attenuates the Transcriptional Activity of NRF1 and Potentiates Proteasome Inhibitor Cytotoxicity
por: Northrop, Amy, et al.
Publicado: (2020)

Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy
por: Cuadrado, Antonio, et al.
Publicado: (2017)

Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints
por: Lastra, Diego, et al.
Publicado: (2022)

COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
por: Li, Jian, et al.
Publicado: (2022)

Phytochemical activators of Nrf2: a review of therapeutic strategies in diabetes: Phytochemical activators of Nrf2
por: Qin, Si, et al.
Publicado: (2022)

Effects of Nrf2 Deficiency on Bone Microarchitecture in an Experimental Model of Osteoporosis
por: Ibáñez, Lidia, et al.
Publicado: (2014)

Reduced Blood RGS2 Expression in Mild Cognitive Impairment Patients
por: Milanesi, Elena, et al.
Publicado: (2021)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

The Role of Nrf2 Activity in Cancer Development and Progression
por: Zimta, Alina-Andreea, et al.
Publicado: (2019)

Nrf2 Transcriptional Activity Governs Intestine Development
por: Kopacz, Aleksandra, et al.
Publicado: (2022)

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
por: Pajares, Marta, et al.
Publicado: (2016)

Discovery of 4-Anilinoquinolinylchalcone Derivatives as Potential NRF2 Activators
por: Kao, Yu-Tse, et al.
Publicado: (2020)

The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
por: Jung, Kyeong-Ah, et al.
Publicado: (2010)

The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
por: Gao, Bifeng, et al.
Publicado: (2014)

NRF2 Activation by Nitrogen Heterocycles: A Review
por: Egbujor, Melford C., et al.
Publicado: (2023)

Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators
por: Mondal, Debasis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5av1bnoajfmsvkc047vmf0pk7b